CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $210,337 | -19.1% | 4,634 | +0.0% | 0.00% | – |
| Q2 2023 | $260,040 | -31.5% | 4,632 | -44.8% | 0.00% | – |
| Q1 2023 | $379,524 | +100.1% | 8,391 | +79.8% | 0.00% | – |
| Q4 2022 | $189,714 | +287.2% | 4,667 | +528.1% | 0.00% | – |
| Q3 2022 | $49,000 | -99.3% | 743 | -99.4% | 0.00% | -100.0% |
| Q2 2022 | $7,529,000 | -3.4% | 123,892 | -0.2% | 0.00% | 0.0% |
| Q1 2022 | $7,790,000 | +3854.3% | 124,090 | +4663.5% | 0.00% | – |
| Q4 2021 | $197,000 | -40.5% | 2,605 | -11.8% | 0.00% | – |
| Q3 2021 | $331,000 | -51.5% | 2,954 | -30.0% | 0.00% | – |
| Q2 2021 | $683,000 | -92.9% | 4,217 | -94.6% | 0.00% | -100.0% |
| Q1 2021 | $9,575,000 | -61.2% | 78,582 | -51.3% | 0.01% | -66.7% |
| Q4 2020 | $24,692,000 | +450.9% | 161,266 | +201.0% | 0.02% | +400.0% |
| Q3 2020 | $4,482,000 | +3.2% | 53,585 | -9.3% | 0.00% | 0.0% |
| Q2 2020 | $4,344,000 | +3241.5% | 59,103 | +1833.4% | 0.00% | – |
| Q1 2020 | $130,000 | -98.4% | 3,057 | -97.7% | 0.00% | -100.0% |
| Q4 2019 | $8,169,000 | +440.3% | 134,140 | +263.6% | 0.01% | +400.0% |
| Q3 2019 | $1,512,000 | +7100.0% | 36,896 | +7651.3% | 0.00% | – |
| Q2 2019 | $21,000 | +31.2% | 476 | +1.9% | 0.00% | – |
| Q1 2019 | $16,000 | -89.3% | 467 | -91.2% | 0.00% | – |
| Q4 2018 | $150,000 | -50.5% | 5,285 | -22.7% | 0.00% | – |
| Q3 2018 | $303,000 | -98.4% | 6,840 | -97.8% | 0.00% | -100.0% |
| Q2 2018 | $18,673,000 | +1574.7% | 317,820 | +1200.7% | 0.01% | +400.0% |
| Q1 2018 | $1,115,000 | -18.4% | 24,435 | -58.1% | 0.00% | 0.0% |
| Q4 2017 | $1,367,000 | +170.2% | 58,265 | +105.3% | 0.00% | – |
| Q3 2017 | $506,000 | +6225.0% | 28,384 | +5576.8% | 0.00% | – |
| Q2 2017 | $8,000 | -94.7% | 500 | -92.8% | 0.00% | – |
| Q1 2017 | $150,000 | – | 6,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |